About this trial
This prospective cohort study aims to identify the clinical, laboratory, and echocardiographic predictors of outcomes among neonates diagnosed with persistent pulmonary hypertension of the newborn at Assiut University Children Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
- Neonates (term and preterm) admitted to the NICU
Clinical and echocardiographic evidence of pulmonary hypertension
Written informed consent from parents or legal guardians
Disqualifiers
- Major structural cyanotic congenital heart disease
Lethal congenital anomalies or chromosomal abnormalities incompatible with survival
Trial population
Term and preterm neonates admitted to the Neonatal Intensive Care Unit of Assiut University Children Hospital with clinical and echocardiographic evidence of persistent pulmonary hypertension.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
In-hospital mortality
Proportion of neonates with persistent pulmonary hypertension who die before hospital discharge.
Secondary outcomes
Duration of mechanical ventilation
Total number of days of invasive mechanical ventilation.
Duration of oxygen therapy
Total number of days requiring supplemental oxygen.
Use of sildenafil
Proportion of neonates who receive sildenafil therapy.
Use of inotropes
Proportion of neonates who receive inotropic support
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: